Interchange Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,496	Closed	-$206K	–	271
2024 Q2	$206K	Buy	+1,496	New	+$206K	0.08%	250
2021 Q1	–	Sell	-1,535	Closed	-$147K	–	785
2020 Q4	$147K	Buy	+1,535	New	+$147K	0.08%	252